Central Hospital of Guangdong Nongken, Zhanjiang Cancer Hospital
Central Hospital of Guangdong Nongken, Zhanjiang Cancer Hospital
Zhanjiang, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations | EGFR Gene Mutation; Non-small Cell Carcinoma | Active, not recruiting | Phase 3 | 2025-10-15 | NCT04695925 |